Biological functions of miR-183 on chemosensitivity of laryngeal cancer cells

被引:0
|
作者
Lou, Guangming [1 ]
Chen, Jinghua [1 ]
Wu, Lizhen [2 ]
Yu, Yongming [1 ]
Huang, Yuyong [1 ]
机构
[1] Fujian Med Univ, Dept Ear Nose & Throat, Longyan Affiliated Hosp 1, 105,North Jiu Yi Rd, Longyan 364000, Fujian, Peoples R China
[2] Fujian Med Univ, Dept Castroendoscop Surg, Longyan Affiliated Hosp 1, Longyan, Peoples R China
来源
JOURNAL OF BUON | 2021年 / 26卷 / 03期
关键词
miR-183; laryngeal cancer; drug resistance; 5-fluorouracil; TBX3; CHEMOTHERAPY; MICRORNA; TBX3; RATES;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The purpose of this study was to investigate the effect of miR-183 on the sensitivity of laryngeal cancer cells to 5-fluorouracil (5-Fu) and its mechanism, so as to provide certain references for the clinical prevention of drug resistance in laryngeal cancer cells. Methods: Cell proliferation was determined via 5-ethynyl-2'-deoxyuridine (EdU) staining. Colony formation assay was applied to test the colony-formation ability in each group of cells. In addition, the expression levels of apoptosisrelated proteins were measured through Western blotting. Wound-healing assay and Transwell assay were performed to examine the migratory and invasive abilities. Furthermore, the tumor-forming ability in vitro was detected by subcutaneous tumor formation assay. Results: MiR-183 declined remarkably in 5-Fu-RES group compared with that in Control group. After overexpressing miR-183, the DNA replication and colony forming abilities of the resistant human primary laryngeal cancer cells were weakened notably. MiR-183 overexpression could obviously up-regulate Bax and inhibit Bcl-2 in the resistant human primary laryngeal cancer cells. Moreover, the overexpression of miR-183 was able to repress the migratory and invasive abilities of the resistant human primary laryngeal cancer cells. Further, overexpression of miR-183 restrained the in vitro tumor-forming ability of the resistant human primary laryngeal cancer cells markedly. Finally, it was revealed that TBX3 in the resistant human primary laryngeal cancer cells was suppressed distinctly, while that of PTEN was up-regulated evidently after overexpressing miR-183. Conclusions: The overexpression of miR-183 can inhibit the drug resistance of the human primary laryngeal cancer cells to 5-Fu, promote cancer cell apoptosis and inhibit their invasive and migratory abilities at the same time, whose mechanism may be associated with the targeted regulation of the TBX3/PTEN signaling pathway by miR-183.
引用
收藏
页码:785 / 791
页数:7
相关论文
共 50 条
  • [1] Mir-183 functions as an oncogene via decreasing PTEN in breast cancer cells
    Samaneh Mohammaddoust
    Majid Sadeghizadeh
    Scientific Reports, 13
  • [2] Mir-183 functions as an oncogene via decreasing PTEN in breast cancer cells
    Mohammaddoust, Samaneh
    Sadeghizadeh, Majid
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [3] Dysregulated miR-183 inhibits migration in breast cancer cells
    Aoife J Lowery
    Nicola Miller
    Roisin M Dwyer
    Michael J Kerin
    BMC Cancer, 10
  • [4] Dysregulated miR-183 inhibits migration in breast cancer cells
    Lowery, Aoife J.
    Miller, Nicola
    Dwyer, Roisin M.
    Kerin, Michael J.
    BMC CANCER, 2010, 10
  • [5] The miR-183 Cluster: Biogenesis, Functions, and Cell Communication via Exosomes in Cancer
    Li, Shuhui
    Meng, Wei
    Guo, Ziyi
    Liu, Min
    He, Yanyun
    Li, Yanli
    Ma, Zhongliang
    CELLS, 2023, 12 (09)
  • [6] miR-183 functions as an oncogene by targeting ABCA1 in colon cancer
    Bi, Da-Peng
    Yin, Cheng-Hua
    Zhang, Xiao-Yue
    Yang, Na-Na
    Xu, Jia-You
    ONCOLOGY REPORTS, 2016, 35 (05) : 2873 - 2879
  • [7] Inhibition of miR-183 Induces Insulin in Dental Pulp Cells
    Nozaki, Tadashige
    Ohura, Kiyoshi
    JOURNAL OF HARD TISSUE BIOLOGY, 2017, 26 (04) : 319 - 322
  • [8] miR-183 as a molecular and protective biomarker for cancer in schizophrenic subjects
    Rizos, E.
    Siafakas, N.
    Koumarianou, A.
    Katsantoni, E.
    Filippopoulou, A.
    Ntounas, P.
    Touloumis, Ch.
    Kastania, A.
    Zoumpourlis, V.
    ONCOLOGY REPORTS, 2012, 28 (06) : 2200 - 2204
  • [9] miR-183 inhibits invasion of gastric cancer by targeting Ezrin
    Cao, Long-Long
    Xie, Jian-Wei
    Lin, Yao
    Zheng, Chao-Hui
    Li, Ping
    Wang, Jia-Bin
    Lin, Jian-Xian
    Lu, Jun
    Chen, Qi-Yue
    Huang, Chang-Ming
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (09): : 5582 - U1968
  • [10] MiR-183 and miR-494 as risk biomarkers for breast cancer development
    Macedo, T.
    Evangelista, A. F.
    Marino, A. F. L.
    Vieira, R. A. C.
    Longatto, A. F.
    Silva, V. A. O.
    Vidal, D. O.
    Marques, M. M. C.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S32 - S32